FRE — Firebrick Pharma Income Statement
0.000.00%
- AU$8.56m
- AU$7.23m
- AU$0.11m
Annual income statement for Firebrick Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.004 | 0.001 | 0.015 | 0.293 | 0.106 |
| Cost of Revenue | |||||
| Gross Profit | — | — | -0.023 | 0.105 | 0.035 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4.88 | 6.86 | 3.93 | 3.15 | 3.2 |
| Operating Profit | -4.87 | -6.86 | -3.91 | -2.86 | -3.09 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.8 | -6.8 | -1.18 | -2.63 | -3.06 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.8 | -6.8 | -1.18 | -2.63 | -3.06 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.8 | -6.8 | -1.18 | -2.63 | -3.06 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.8 | -6.8 | -1.18 | -2.63 | -3.06 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.033 | -0.04 | -0.007 | -0.013 | -0.012 |
| Dividends per Share |